Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Cambrian BioPharma Inc files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian C. Stephenson - $1.13M in FTH purchases and sales in the last 12 months
- MILLENNIUM MANAGEMENT LLC - $679K in FTH purchases and sales in the last 12 months
- James Peyer - $501K in FTH purchases and sales in the last 12 months
- Anand Kiran Parikh - $55K in FTH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Cambrian BioPharma Inc?
Cambrian BioPharma Inc is a corporate entity of Faeth Therapeutics, Inc. (FTH). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Cambrian BioPharma Inc last file a Form 4?
The only primary Form 4 on record is dated 1 June 2026.
Has Cambrian BioPharma Inc been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($501K) across all tracked filings.
